When detected early, nine in 10 Australians with bowel cancer can be successfully treated, yet participation in the National Bowel Cancer Screening Program remains low.

Prescribing drugs to reduce the risk of cancer is a new development in primary cancer prevention.

How should GPs and patients prioritise which preventive health activities to undertake?

This paper summarises the updated recommendations from the National Health and Medical Research Council pertaining to colorectal cancer screening so that they may be applied in general practice.

Cancer pain is one of the most common and problematic symptoms faced in palliative care.

An update on the various treatment methods available today to tackle pilonidal disease.

Expected frequency trees can be used to promote appropriate patient choice of colorectal cancer screening modality.

Faecal incontinence in residential aged care is highly prevalent, distressing and difficult to treat, and the evidence base for treatment remains deficient.

Clinician/pathologist communication is important for accurate diagnosis of melanocytic skin tumours.

With the advent of new treatments, the outcomes of myeloma have changed drastically in the past decade.

Long-term management requires an understanding of the range of causes and benefits from a shared decision-making approach, with discussion about potential risks and benefits of therapy.

There is a broad range of pathologies that may present as a sellar or parasellar mass.

Diseases of the adrenal gland occur rather more frequently than is appreciated and provide a series of challenges for the treating practitioner.

This model of care recommends a systemic, coordinated, multidisciplinary approach to survivorship, using pathways of care that support wellness, disease prevention and cancer surveillance.

Early identification of all skin cancers enables improved patient outcomes and results in a wider range of treatment options being available locally in general practice.